link: http://ift.tt/1jaUDvL
Hot And Trending...
Trending
- How negative interest rates work?
- Malinvestment and the Austrian Business Cycle, as explained by Yogi Berra
- 2008 Was Just a Tremor; The Real Economic Earthquake Is Coming https://t.co/SQo6W8cDxA @SchiffGold
- Tom Woods and Robert Murphy's new podcast "Contra Krugman" has finally started!!
- For all of 2017 U.S. GDP grew by 2.3%. This is slightly below the 2.2% average #GDP growth during Obama's 2nd term, and below the 2.6% and 2.9% growth rates of i2014 and 2015. Yet according to Trump the economy was a disaster under Obama, but is booming under his administration!
- Global Data: A New Scapegoat for the Federal Reserve http://bit.ly/1qmyOgp @SchiffGold
- Ep. 281: Weak Jobs Report Doesn't Rain on Market Parade: http://bit.ly/2gyn0Z7 via @YouTube
- #Macy's stock price is down over 40% in the past 3 months on weaker sales. This supports my forecast for a weak holiday shopping season.
- Why the jobs picture is even worse than you think http://bit.ly/1LojYyN
- Ep. 282: Hurricanes Rain On Market's Parade: http://bit.ly/2f1E46a via @YouTube
Wednesday, September 23, 2015
CEO who raised price of drug by 5000%
I know everyone is hating on this guy, but here is my view on the whole thing. So yeah this guy may be a prick, but from purely an economic sense, what he did might not be so terrible. The patent that Turing Pharmaceuticals purchased is for Daraprim, and from what I know, the patent is actually expired, all he bought was the right to sell the branded drug. No one is producing it generically - yet. With the massive price hike surely some pharmaceutical companies will come in with generic versions of Daraprim and undercut Turing's prices and increase supply until there is competitive equilibrium. What do you think?